Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
Baxter
QuintilesIMS

Generated: March 26, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Sargramostim

« Back to Dashboard

US Patents for Sargramostim

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Sargramostim ➤ Try a Free Trial Trilayer coated pharmaceutical packaging SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Try a Free Trial
Sargramostim ➤ Try a Free Trial TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial
Sargramostim ➤ Try a Free Trial Compositions comprising serum albumin and p53 peptides fusion proteins University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Try a Free Trial
Sargramostim ➤ Try a Free Trial Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease Reponex Pharmaceuticals A/S (Horsholm, DK) ➤ Try a Free Trial
Sargramostim ➤ Try a Free Trial Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer YALE UNIVERSITY (New Haven, CT) ➤ Try a Free Trial
Sargramostim ➤ Try a Free Trial Method of treating pancreatic cancer ChemoCentryx, Inc. (Mountain View, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Sargramostim

Drugname Country Document Number Estimated Expiration Related US Patent
Sargramostim Argentina 082615 2030-08-09 ➤ Try a Free Trial
Sargramostim Australia 2010249031 2030-05-12 ➤ Try a Free Trial
Sargramostim Australia 2010249033 2030-05-12 ➤ Try a Free Trial
Sargramostim Australia 2011252925 2030-05-12 ➤ Try a Free Trial
Sargramostim Australia 2012318242 2030-05-12 ➤ Try a Free Trial
Sargramostim Australia 2013352436 2030-05-12 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Argus Health
McKinsey
Fuji
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.